1 / 31

NTP Year-end Evaluation and Planning Workshop

NTP Year-end Evaluation and Planning Workshop. Nov 14-18, 2011 Bohol. City Profile, 2011. Population, 2011: _________ (Source: ____ ) No. of health centers: ___ No. of health personnel:. City Profile, 2011. No. of Existing TML (TB Microscopy Laboratory) ___ HC- based

avedis
Download Presentation

NTP Year-end Evaluation and Planning Workshop

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. NTP Year-end Evaluation and Planning Workshop Nov 14-18, 2011 Bohol

  2. City Profile, 2011 • Population, 2011: _________ (Source: ____ ) • No. of health centers: ___ • No. of health personnel:

  3. City Profile, 2011 • No. of Existing TML (TB Microscopy Laboratory) ___ HC- based ___ with full time Med Tech ___ without full time Med Tech ___ Hospital- based (DOTS-engaged) ___ public ___ private ___ Private facilities (DOTS-engaged) • Total no. of lying-in clinic(s): ___ • Total no. of Puericulture Center(s): ___ • Total no. of NGOs present: ___ • Total no. of NGOs involved in NTP: ___

  4. City Profile, 2011 • No. of hospital(s) and DOTS engagement: __ (Total) • No. of TBDC at:

  5. City Profile, 2011 • No of certified and accredited DOTS facilities

  6. PERFORMANCE

  7. LaboratoryPerformance

  8. Trend of Total Slide Reading Errors 2009-Q1-Q3 2011

  9. Trend of Smear Preparation based on 6 Assessment Points, 2009-Q1-Q3 2011

  10. QA Monitoring, 2011 • Total no. of lab monitoring done: ___ • Total no. of laboratories monitored: ___

  11. CASE-FINDING & CASE-HOLDINGPERFORMANCE

  12. 2009 Performance

  13. 2010 Performance

  14. Q1-Q3, 2011 Performance

  15. Over-all Performance

  16. BOTTLENECK

  17. 2012 DIRECTION

  18. TARGETS

  19. ACTIVITIESin Achieving 2012 Direction

  20. PhilPACT Strategy 1: Localize implementation of TB control

  21. PhilPACT Strategy 2: Monitor health system performance

  22. PhilPACT Strategy 3: Engage ALL health care providers

  23. PhilPACT Strategy 4: Promote and strengthen positive behaviour of communities

  24. PhilPACT Strategy 5: Address MDR-TB,TB/HIV and needs of vulnerable populations

  25. PhilPACT Strategy 6: Regulate and make available quality TB diagnostic tests and drugs

  26. PhilPACT Strategy 7: Certify and accredit TB care providers

  27. PhilPACT Strategy 8: Secure adequate funding and improve allocation & efficiency of fund utilization

  28. CHALLENGES in Attaining 2012 Direction

  29. TECHNICAL Challenges Recommendation/Plan

  30. MANAGERIAL Challenges Recommendation/Plan

  31. ADMINISTRATIVE Challenges Recommendation/Plan

More Related